Ulp1 通过 Pichia pastoris 中的 INO1 调节细胞增殖
Junjie Yang1, Bo Zhong1, Lan Yang1
1College of Life Sciences and Medicine, Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, Zhejiang Sci-Tech University, Hangzhou 310018, China.
Genes
|November 27, 2024
概括
Ulp1蛋白通过调节INO1基因来调节Pichia pastoris中的细胞增殖. 这种调节是独立于INO1的.
科学领域:
- *酵母分子生物学 酵母分子生物学
- * 细胞循环调节的作用
- * 基因表达分析分析
背景情况:
- *Ulp1是Saccharomyces cerevisiae中的关键细胞循环调节剂,对于通过G2/M阶段的进展至关重要.
- *Ulp1在Pichia pastoris细胞周期调节中的确切作用和机制尚未完全阐明.
- *研究Ulp1在Pichia pastoris中的功能对于理解细胞分裂的保存机制至关重要.
研究的目的:
- * 调查Ulp1在Pichia pastoris细胞周期调节中的作用.
- *阐明Ulp1影响细胞增殖的机制,重点关注其与INO1基因的相互作用.
- * 确定Ulp1的调节功能是否依赖INO1的酶活性.
主要方法:
- *使用FLP-FRT系统在Pichia pastoris中生成Ulp1淘汰菌株.
- *RNA测序 (RNA-seq) 用于分析Ulp1淘汰菌株的全球基因表达变化.
- *对Ulp1淘汰和INO1过度表达菌株的细胞增殖的评估,包括内醇补充实验.
主要成果:
- *在Ulp1绝杀菌株中观察到INO1和其他基因的显著下调.
- *Ulp1淘汰菌株中INO1救援细胞增殖缺陷的过度表达,证实了Ulp1通过INO1.1的调节作用.
- *外源性内醇补充剂没有挽救细胞增殖,这表明INO1的酶活性不需要Ulp1的功能.
结论:
- *Ulp1通过INO1基因调节Pichia pastoris的细胞增殖,独立于INO1的酶活性.
- *这些发现为Ulp1在细胞周期控制和酵母细胞分裂中的作用提供了新的见解.
- *需要进一步的研究,才能充分理解涉及Ulp1和INO1的复杂监管途径.
相关概念视频
01:23Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
02:36Cells Coordinate Growth and Proliferation
4.5K
Cell size is a significant factor impacting cellular design, function, and fitness. There exists some internal coordination by which cells double their masses before division, thus, achieving homeostasis. Coordination between cell growth and proliferation depends on the checkpoints in between cell cycle phases. Loss of coordination or failure in the checkpoint mechanism can drive the cell to uncontrolled growth and loss of cellular function. Like dividing cells that coordinate cellular growth,...
4.5K
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
01:31Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K